← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Invesco India Midcap Fund

Direct Plan · Growth · Mid Cap · Scheme code 120403

NAV₹246.5400as on 27 Aug 2026
Fund houseInvesco Mutual Fund
CategoryMid Cap
Plan & optionDirect · Growth
History13.7 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 1.2410.2114.10 14.3325.7121.66 25.7019.9721.22
Nifty Midcap 150
benchmark		 1.724.387.82 13.0017.68— ——20.15
Mid Cap
category median		 ——— 10.2119.8417.23 —17.08—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 15.9% 1.21 1.65 1.00 5.52% -34.1% 88.13
Nifty Midcap 150
benchmark		 15.7%0.71 0.97—— -21.1%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 46 months this scheme and its benchmark share.

Growth of ₹100 since launch

-244809841,4882014201620182020202220242026InvestVerdict

Drawdown from peak (%)

0%-11%-22%-33%2014201620182020202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
623 -20.0% 18.5% 103.1% 11%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Invesco India Midcap Fund

Direct Plan · Growth

Allocation

By asset

Equity99.36%
Cash & Equivalents0.64%

By market cap

Large Cap18.30%
Mid Cap57.00%
Small Cap24.06%

Concentration

Number of stocks44
Top 5 stocks26.69%
Top 10 stocks47.29%
Top 20 stocks76.07%
Largest holding7.09%
Largest sectorRetailing 15.52%
Effective stocks28.7
Cash0.64%
InvestVerdict

Invesco India Midcap Fund

Direct Plan · Growth · holdings

Top 18 holdings

#CompanySector% of fund
1— Realty7.09%
2— Banks5.58%
3— Capital Markets5.08%
4— Banks4.47%
5— Retailing4.47%
6— Healthcare Services4.37%
7— Healthcare Services4.30%
8— Transport Services4.18%
9— Retailing3.95%
10— Finance3.80%
11— Banks3.77%
12— Cement & Cement Products3.08%
13— Pharmaceuticals & Biotechnology3.06%
14— Insurance3.05%
15— Pharmaceuticals & Biotechnology2.98%
16— Chemicals & Petrochemicals2.80%
17— Retailing2.74%
18— Industrial Manufacturing2.68%

Sector split

Retailing — 15.5%Banks — 13.8%Healthcare Services — 10.6%Realty — 9.3%Pharmaceuticals & Biotechnology — 7.0%Finance — 5.2%Capital Markets — 5.1%Insurance — 4.7%Consumer Durables — 4.5%Other — 24.3%Retailing15.5%Banks13.8%Healthcare Services10.6%Realty9.3%Pharmaceuticals & Biotech…7.0%Finance5.2%Capital Markets5.1%Insurance4.7%Consumer Durables4.5%Other24.3%
Retailing15.52%
Banks13.82%
Healthcare Services10.60%
Realty9.25%
Pharmaceuticals & Biotechnology7.04%
Finance5.17%
Capital Markets5.08%
Insurance4.73%
Consumer Durables4.51%
Transport Services4.18%

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹1,070,678 ₹470,678 23.39%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 29 Aug 2026.